Labetalol Hydrochloride Injection, Solution
Product Images NDC 55154-4747

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 55154-4747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4feaaa59 D306 4151 941e 0775ab1e75b3 00

4feaaa59 D306 4151 941e 0775ab1e75b3 00
Labetalol Hydrochloride Injection, USP 20 mg/4 mL (5 mg/mL) sterile cartridge units with Luer Lock. The label notes a pack of 5 cartridges, each containing 4 mL of solution. It is intended for intravenous injection only and requires use with Carpuject holders. Distributed by Cardinal Health 107, LLC, this single-dose package is for institutional use and is made in Italy.*
FDA Label Image

Labetalol 01

FDA Label Image

Labetalol 02

Labetalol 02
Chemical structure diagram of Labetalol Hydrochloride showing molecular connectivity including aromatic rings and functional groups with a hydrochloride component.*
FDA Label Image

Labetalol 03

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.